Table 3 EPHX1 (rs1051740), NQO1 (rs1800566) and PON1 (rs662) genotype distributions according to the lymphoma diagnose
EPHX1 (rs1051740) | NQO1(rs1800566) | PON1 (rs662) | |||||||
|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | CC | CT | TT | AA | AG | GG | |
Controls | 113 (52.8) | 83 (38.8) | 18 (8.4) | 123 (57.5) | 78 (36.4) | 13 (6.0) | 100 (46.7) | 104 (48.6) | 10 (4.7) |
NHL | 109 (58.6) | 65 (34.9) | 12 (6.5) | 122 (63.2) | 63 (32.6) | 8 (4.1) | 76 (39.2) | 88 (45.4) | 30 (15.5) |
p (OR; 95% CI) | 0.458 (0.8;0.4-1.6) | 0.513 (0.7;0.3-1.6) | 0.0005 (3.7;1.8-7.9) | ||||||
FL | 78 (59.5) | 46 (35.1) | 7 (5.3) | 85 (63.0) | 45 (33.3) | 5 (3.7) | 55 (40.7) | 61 (45.2) | 19 (14.1) |
p (OR; 95% CI) | 0.394 (0.6;0.2-1.5) | 0.467 (0.6;0.2-1.7) | 0.004 (3.3;1.5-7.4) | ||||||
DLBCL | 21 (61.8) | 10 (29.4) | 3 (8.8) | 19 (55.9) | 12 (35.3) | 3 (8.8) | 11 (31.4) | 18 (51.4) | 6 (17.1) |
p (OR; 95% CI) | 0.8 (1.1;0.3-3.8) | 0.818 (1.5;0.4-5.6) | 0.016 (4.2;1.4-12.5) | ||||||
HL | 9 (45.0) | 9 (45.0) | 2 (10.0) | 9 (45.0) | 9 (45.0) | 2 (10.0) | 7 (33.3) | 11 (52.4) | 3 (14.3) |
p (OR; 95% CI) | 0.861 (1.2;0.3-5.6) | 0.835 (1.7;0.4-8.2) | 0.181 (3.4; 0.9-13.5) | ||||||